ZIMV Earnings Prediction
The chart below shows how ZIMV performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ZIMV sees a +6.05% change in stock price 10 days leading up to the earnings, and a +3.87% change 10 days following the report. On the earnings day itself, the stock moves by -3.12%. This data can give you a slight idea of what to expect for the next quarter's release.
ZIMV Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
111.52M
-1.37%
8.04%
Gross Margin
59.92%
5.27%
0.79%
Operating Margin
1.47%
130.56%
-152.88%
Net Margin
-8.67%
-55.77%
193.90%
EPS
-0.43
-96.58%
437.50%
No Data Available
ZIMV Earnings Analysis
ZimVie Inc Corporation (ZIMV.O) Earnings Conference Call
Positive
Business Transformation Focus: 2024 was a transformational year for ZimVie, marked by the sale of the spine business, allowing the company to focus solely on dental solutions.
Strong Market Revenue Performance: ZimVie delivered $450 million in full-year revenue, demonstrating strong market presence despite challenges.
EBITDA Margin Improvement: The company improved adjusted EBITDA margins by over two percentage points for the year, reflecting operational efficiency.
Strong Cash Generation: In Q4 alone, ZimVie generated over $21 million in operating cash flow, showcasing strong cash generation capabilities.
Debt Reduction and Stability: The sale of the spine business allowed ZimVie to significantly reduce debt, enhancing financial stability.
Leadership Appointment for Growth: The appointment of a new Vice President of Americas Sales is expected to strengthen the commercial team and drive growth in the largest market.
Dental Implant Quality Feedback: ZimVie’s premium dental implants, particularly the TSX and T3 PRO, received positive feedback for their quality and effectiveness in reducing peri-implant infection risks.
Biomaterials Portfolio Growth: The biomaterials portfolio grew by 2% during the year, indicating strong demand and customer acquisition.
Digital Dentistry Revenue Surge: The digital dentistry business achieved record revenue in 2024, with a growth rate of over 10% for the year and over 20% in Q4, highlighting successful product offerings.
Implant Concierge Growth: The Implant Concierge service grew by 14% for the year, demonstrating its value to clinicians and potential for future expansion.
Surgical Guide Sales Surge: Surgical guide sales increased by 39% due to the launch of the 5.4 RealGUIDE software, showcasing innovation in digital solutions.
Positive GAAP Operating Income: ZimVie expects to achieve positive GAAP operating income in 2025, indicating a strong outlook for profitability.
Projected Operating Cash Flow: The company anticipates generating operating cash flow of approximately $30 million to $40 million in 2025, more than double the amount generated in 2024.
Negative
Q4 Sales Decline: Total third-party net sales for Q4 2024 were $111.5 million, a decrease of 1.4% in reported rates and a decline of 0.9% in constant currency, primarily due to declines in US implants and oral scanners.
Third-Party Sales Decline: In the US, third-party net sales for Q4 2024 of $64.4 million declined 1.5% compared to the prior year, driven by weakness during the last two weeks of the quarter in implant sales and lower oral scanner sales.
Sales Decline Overview: For the full year 2024, total third-party net sales were $449.7 million, a decrease of 1.6% in reported rates and a decline of 1.2% in constant currency versus the prior year.
International Sales Decline: Outside of the US, third-party net sales of $182.9 million decreased 2.5% on a reported basis and 1.5% in constant currency for the full year 2024.
R&D Expense Decrease: Fourth quarter adjusted research and development expenses were $5.8 million, a decrease from $6.5 million in the prior year, indicating reduced investment in new product development.
2025 Revenue Projections: The company expects 2025 revenue of between $445 million to $460 million, reflecting a 1% decline to 2% reported growth, indicating a challenging market outlook.
Net Sales Projections: The first quarter of 2025 is expected to see net sales in the range of $112 million to $114 million, reflecting a range of minus 2% to flat growth, indicating continued market challenges.
Interest Expense Impact: The company anticipates interest expense to be in the range of $7.5 million to $8 million, which could impact profitability.
Sales Decline Concerns: Despite improvements in adjusted EBITDA margins, the overall sales decline raises concerns about long-term growth prospects.
ZIMV FAQs
How does ZIMV typically perform around its earnings report dates?
Is ZimVie Inc (ZIMV) Q4 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
ZIMV Earning Call Sentiment
ZimVie Inc. (ZIMV) Q4 2024 Earnings Call Transcript
ZIMV.O
-4.12%Positive
The earnings call shows mixed signals: strong EPS growth and improved margins, but declining revenue and unclear guidance on key markets. The Q&A reveals some stability and potential growth areas, yet concerns about market recovery and financing impacts remain. Despite shareholder return plans and debt management, the lack of clarity on critical growth drivers and external pressures like tariffs and supply chain issues suggest a neutral sentiment, especially without market cap information to gauge potential stock movement.
